Literature DB >> 9455825

Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure.

P Fénichel1, C Sosset, P Barbarino-Monnier, B Gobert, S Hiéronimus, M C Béné, M Harter.   

Abstract

Autoimmunity may be involved in idiopathic premature ovarian failure (POF). However, the frequency, physiopathology and potential reversibility of autoimmune oophoritis needs clarification. Using an ELISA against whole tissue homogenate as antigen, from human ovaries at different ages, positive circulating ovarian antibodies (AOA) were found in 59% of patients with primitive idiopathic POF (27/46); 20/27 were positive for IgG isotype, 9/27 for IgM and 8/27 for IgA. Specificity of AOA was examined (i) by comparison to different control groups; mean values of the three subclasses of immunoglobins were significantly higher in POF women than in normally cycling fertile young women (n = 23) and fertile young men (n = 17), in untreated Grave's disease (n = 35) or in women with positive antinuclear factor (n = 25); and (ii) by assessing possible cross-reaction; only six out of the 27 positive sera reacted with other tissues (thyroid, pancreas, adrenal), including four clinical polyendocrinopathies. Significance of AOA was explored (i) by comparison with postmenopausal women (n = 40) and older women (n = 15), who did not have enhanced ratios of AOA, thereby excluding a potential role of high FSH values; (ii) by analysing the factors time and surgery; no relation could be found either with the duration of amenorrhoea (6 months to 21 years) or with the history of an ovarian biopsy (12/47) in the absence of any associated pelvic surgery; and (iii) by screening for other immunological factors; familial or personal autoimmune disease (8/46), HLA DR3 (10/42), HLA DR4 (11/42), associated autoantibodies (thyroperoxidase, adrenal, beta islets, parathyroid, DNA, smooth muscles) (12/42). If one positive AOA isotype was present, a second immunological factor was found in 45% of cases. Spontaneous pregnancies during oestrogen therapy occurred in four cases, including three women with positive AOA. Circulating AOA detected by an ELISA may represent a practical and suitable marker for diagnosis of POF. Its use for prognosis and rational treatment needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455825     DOI: 10.1093/humrep/12.12.2623

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  14 in total

1.  Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure.

Authors:  Seby L Edassery; Seerin V Shatavi; Jeremy P Kunkel; Charles Hauer; Cosima Brucker; Krishna Penumatsa; Yi Yu; James A Dias; Judith L Luborsky
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

2.  Preferential replication of vaccinia virus in the ovaries is independent of immune regulation through IL-10 and TGF-β.

Authors:  Yuan Zhao; Yan Fei Adams; Michael Croft
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

3.  Antiovarian antibodies in primary Sjogren's syndrome.

Authors:  Kyriaki Euthymiopoulou; Alexios J Aletras; Panagiota Ravazoula; Anna Niarakis; Dimitris Daoussis; Ioannis Antonopoulos; Stamatis-Nick Liossis; Andrew P Andonopoulos
Journal:  Rheumatol Int       Date:  2007-05-31       Impact factor: 2.631

Review 4.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

5.  The role of genetic and autoimmune factors in premature ovarian failure.

Authors:  Nigyar N Shamilova; Larisa A Marchenko; Nataliya V Dolgushina; Dmitry V Zaletaev; Gennady T Sukhikh
Journal:  J Assist Reprod Genet       Date:  2013-03-16       Impact factor: 3.412

Review 6.  Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update.

Authors:  Eusebio S Pires
Journal:  J Assist Reprod Genet       Date:  2010-06-03       Impact factor: 3.412

7.  Can anti-ovarian antibody testing be useful in an IVF-ET clinic?

Authors:  Eusebio S Pires; Firuza R Parikh; Purvi V Mande; Shonali A Uttamchandani; Sujata Savkar; Vrinda V Khole
Journal:  J Assist Reprod Genet       Date:  2010-10-12       Impact factor: 3.412

8.  Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study.

Authors:  Thierry Forges; Patricia Monnier-Barbarino; Frédérique Guillet-May; Gilbert C Faure; Marie-Christine Béné
Journal:  Eur J Clin Pharmacol       Date:  2006-07-18       Impact factor: 2.953

Review 9.  Intraovarian control of early folliculogenesis.

Authors:  Aaron J W Hsueh; Kazuhiro Kawamura; Yuan Cheng; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

Review 10.  Menarche delay and menstrual irregularities persist in adolescents with type 1 diabetes.

Authors:  Bahareh M Schweiger; Janet K Snell-Bergeon; Rossana Roman; Kim McFann; Georgeanna J Klingensmith
Journal:  Reprod Biol Endocrinol       Date:  2011-05-06       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.